Valiant Laboratories LtdPharmaceuticalsINE0JWS01017Consolidated₹124.71+2.12 (+1.73%)Jun-26
Valuation
Market Cap₹669.46 Cr
TTM PE41.78x
Forward PE31.77x
PEG-0.06
Book Value₹57.24
P/B2.15x
TTM EPS₹2.95
Fwd EPS₹3.88
TTM Revenue₹305.93 Cr
TTM PAT₹16.00 Cr
TTM EBITDA₹30.54 Cr
TTM EBIT₹24.22 Cr
Last Qtr PAT₹21.10 Cr
Last Qtr EBITDA₹29.27 Cr
Last Qtr EBIT₹26.41 Cr
Profitability
ROE5.15%
ROCE8.35%
TTM NPM5.23%
TTM EBITDA %9.98%
Curr OPM18.17%
Last OPM1.91%
Curr NPM—
Last NPM—
Curr EPS₹3.89
Last EPS₹0.32
Balance sheet
Equity₹54.31 Cr
Reserve₹256.57 Cr
Total Debt₹45.42 Cr
D/E0.15x
Interest %5.07%
Curr Interest₹1.07 Cr
Price / range
Close₹123.26
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.42%
1W-2.17%
1M+36.59%
3M+80.79%
6M+146.90%
1Y+42.61%
2Y+1.07%
3Y—
5Y—
Diwali+79.31%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits
Dividend
0No dividend history.